France Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

France Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices


  • Products Id :- GDMEMC0243DB
  • |
  • Pages: 158
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

France Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

GlobalData's new report, "France Drug Delivery Devices Market Outlook to 2023", provides key market data on the France Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Drug Delivery Devices market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market categories.

Global corporate-level profiles of key companies operating within the France Drug Delivery Devices market.

Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy

Develop business strategies by identifying the key market categories poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Drug Delivery Devices Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Drug Delivery Devices Market, France 11

3.1 Drug Delivery Devices Market, France, Revenue ($m), 2009-2023 11

3.2 Drug Delivery Devices Market, France, Revenue Mix ($m), 2016 13

3.3 Drug Delivery Devices Market, France, Category Contribution by Revenue ($m), 2016 14

3.4 Drug Delivery Devices Market, France, Category Comparison by Revenue ($m), 2009-2023 15

3.5 Drug Delivery Devices Market, France, Revenue ($m), 2009-2016 16

3.6 Drug Delivery Devices Market, France, Revenue ($m), 2016-2023 18

3.7 Drug Delivery Devices Market, France, Volume (Units), 2009-2023 20

3.8 Drug Delivery Devices Market, France, Volume (Units), 2009-2016 22

3.9 Drug Delivery Devices Market, France, Volume (Units), 2016-2023 24

3.10 Drug Delivery Devices Market, France, Company Share by Revenue ($m), 2016 26

4 Central Venous Catheters Market, France 28

4.1 Central Venous Catheters Market, France, Revenue Mix ($m), 2016 28

4.2 Central Venous Catheters Market, France, Segment Contribution (%), 2016 29

4.3 Central Venous Catheters Market, France, Revenue ($m), 2009-2016 30

4.4 Central Venous Catheters Market, France, Revenue ($m), 2016-2023 32

4.5 Central Venous Catheters Market, France, Volume (Units), 2009-2016 34

4.6 Central Venous Catheters Market, France, Volume (Units), 2016-2023 36

4.7 Central Venous Catheters Market, France, Distribution Share by Revenue ($m), 2015-2016 38

4.8 Central Venous Catheters Market, France, Company Share by Revenue ($m), 2016 39

5 Infusion Systems Market, France 41

5.1 Infusion Systems Market, France, Revenue Mix ($m), 2016 41

5.2 Infusion Systems Market, France, Segment Contribution (%), 2016 42

5.3 Infusion Systems Market, France, Revenue ($m), 2009-2016 43

5.4 Infusion Systems Market, France, Revenue ($m), 2016-2023 45

5.4.1 Ambulatory Infusion Pumps Market, France, Revenue ($m), by Segment, 2009-2016 47

5.4.2 Syringe Pumps Market, France, Revenue ($m), by Segment, 2009-2016 49

5.4.3 Ambulatory Infusion Pumps Market, France, Revenue ($m), by Segment, 2016-2023 51

5.4.4 Syringe Pumps Market, France, Revenue ($m), by Segment, 2016-2023 53

5.5 Infusion Systems Market, France, Volume (Units), 2009-2016 55

5.6 Infusion Systems Market, France, Volume (Units), 2016-2023 57

5.6.1 Ambulatory Infusion Pumps Market, France, Volume (Units), by Segment, 2009-2016 59

5.6.2 Syringe Pumps Market, France, Volume (Units), by Segment, 2009-2016 61

5.6.3 Ambulatory Infusion Pumps Market, France, Volume (Units), by Segment, 2016-2023 63

5.6.4 Syringe Pumps Market, France, Volume (Units), by Segment, 2016-2023 65

5.7 Infusion Systems Market, France, Distribution Share by Revenue ($m), 2015-2016 67

5.8 Infusion Systems Market, France, Company Share by Revenue ($m), 2016 68

6 Metered Dose Inhaler Devices Market, France 70

6.1 Metered Dose Inhaler Devices Market, France, Revenue ($m), 2009-2016 70

6.2 Metered Dose Inhaler Devices Market, France, Revenue ($m), 2016-2023 71

6.3 Metered Dose Inhaler Devices Market, France, Volume (Units), 2009-2016 72

6.4 Metered Dose Inhaler Devices Market, France, Volume (Units), 2016-2023 73

6.5 Metered Dose Inhaler Devices Market, France, Distribution Share by Revenue ($m), 2015-2016 74

6.6 Metered Dose Inhaler Devices Market, France, Company Share by Revenue ($m), 2016 75

7 Needle Free Injections Market, France 77

7.1 Needle Free Injections Market, France, Revenue ($m), 2009-2016 77

7.2 Needle Free Injections Market, France, Revenue ($m), 2016-2023 78

7.3 Needle Free Injections Market, France, Volume (Units), 2009-2016 79

7.4 Needle Free Injections Market, France, Volume (Units), 2016-2023 80

7.5 Needle Free Injections Market, France, Distribution Share by Revenue ($m), 2015-2016 81

7.6 Needle Free Injections Market, France, Company Share by Revenue ($m), 2016 82

8 Overview of Key Companies in France, Drug Delivery Devices Market 84

8.1 B. Braun Melsungen AG 84

8.1.1 Company Overview 84

8.2 GlaxoSmithKline Plc 84

8.2.1 Company Overview 84

8.3 Baxter International Inc 84

8.3.1 Company Overview 84

8.4 AstraZeneca Plc 84

8.4.1 Company Overview 84

8.5 Becton Dickinson and Co 85

8.5.1 Company Overview 85

8.6 Boehringer Ingelheim GmbH 85

8.6.1 Company Overview 85

8.7 Fresenius Kabi AG 85

8.7.1 Company Overview 85

8.8 Pfizer Inc 85

8.8.1 Company Overview 85

8.9 Merck & Co Inc 86

8.9.1 Company Overview 86

8.10 Medtronic Plc 86

8.10.1 Company Overview 86

8.11 Smiths Medical 86

8.11.1 Company Overview 86

8.12 Terumo Corp 86

8.12.1 Company Overview 86

8.13 Hospira Inc 87

8.13.1 Company Overview 87

9 Drug Delivery Devices Market Pipeline Products 88

10 Financial Deals Landscape 93

10.1 Asset Transactions 93

10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 93

10.2 Partnerships 95

10.2.1 Alimera Sciences Enters into Licensing Agreement with pSivida 95

10.2.2 Bluegrass Vascular Enters into Partnership with Merit Medical 96

10.2.3 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 97

10.2.4 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 98

10.2.5 Propeller Health Enters into Agreement with Novartis Pharma 100

10.2.6 Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology 101

10.2.7 Pfizer Terminates its Licensing Agreement with pSivida 102

10.2.8 Biocorp Production Enters into Licensing Agreement 103

10.2.9 Bayer Enters into Licensing Agreement with DelSiTech 104

10.2.10 BioCorRx Enters into Licensing Agreement with Therakine 105

11 Recent Developments 106

11.1 Corporate Communications 106

11.1.1 Jun 28, 2017: Cellectis Appoints Rainer Boehm, M.D. and Herve Hoppenot to Board of Directors 106

11.1.2 Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia 106

11.1.3 Apr 11, 2017: Sanofi Announces Pre-quarterly Results Communication 107

11.1.4 Apr 05, 2017: Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee 108

11.1.5 Mar 30, 2017: Avadel Pharmaceuticals Announces Planned Reduction of French Workforce 108

11.1.6 Mar 06, 2017: EDAP Appoints Vice-President of Global Medical, Regulatory and Quality Affairs in the US 108

11.1.7 Mar 02, 2017: Sanofi's Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charles as New Independent Directors 109

11.1.8 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK 109

11.1.9 Jan 30, 2017: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs 110

11.1.10 Jan 03, 2017: Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Commercial Officer 110

11.1.11 Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare 111

11.1.12 Sep 07, 2016: Sanofi Appoints New Research Head for Immunology and Inflammation 111

11.1.13 Sep 06, 2016: Sanofi Board Of Directors Provides Update 112

11.2 Financial Announcements 112

11.2.1 Jul 12, 2017: Sanofi: Pre-quarterly Results Communication 112

11.2.2 May 17, 2017: EDAP TMS SA Reports First Quarter 2017 Results 113

11.2.3 May 09, 2017: Cellectis Reports 1st Quarter 2017 Financial Results 113

11.2.4 May 09, 2017: Avadel Pharmaceuticals Reports First Quarter 2017 Results 115

11.2.5 Apr 28, 2017: Sanofi Delivers Robust Q1 2017 Financial Results 116

11.2.6 Apr 03, 2017: EDAP Achieves 63% Growth in HIFU Revenue in 2016 121

11.2.7 Mar 07, 2017: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results 122

11.2.8 Mar 06, 2017: Cellectis Reports 4th Quarter and Full Year 2016 Financial Results 123

11.2.9 Feb 23, 2017: EDAP Announces Preliminary Unaudited Full Year 2016 Revenue 125

11.2.10 Feb 08, 2017: Sanofi Delivers 2016 Sales and Business EPS Growth at CER 125

11.2.11 Nov 22, 2016: Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2016 132

11.2.12 Nov 17, 2016: EDAP Achieves 79% Growth in HIFU Revenue for First Nine Months of 2016 135

11.2.13 Nov 07, 2016: Flamel Technologies Reports Third Quarter 2016 Results 135

11.2.14 Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results 136

11.2.15 Sep 08, 2016: Cellectis Reports 2nd Quarter and First Half Year 2016 Financial Results 142

11.2.16 Aug 25, 2016: EDAP Reports 69% Growth in HIFU Revenues and Operating Profit for First Half 2016 144

11.2.17 Jul 29, 2016: Sanofi Announces Q2 2016 Results 145

11.2.18 Jul 29, 2016: Royalty report for Q2 2016 and update on lixisenatide (Lyxumia/Adlyxin) and iGlarLixi 151

11.3 Other Significant Developments 152

11.3.1 Feb 08, 2017: Dr. Reddy's Expands Commercial Operations in Europe 152

11.3.2 Jan 05, 2017: Avadel Pharmaceuticals Provides 2017 Guidance and Business Update 152

11.4 Product News 153

11.4.1 Nov 14, 2016: Aguettant's Range of Emergency Injectable Medicine in Ready-to-administer Syringes is Going Global 153

11.5 Strategy And Business Planning 153

11.5.1 Nov 21, 2016: UNITHER Pharmaceuticals opens a Chinese subsidiary: Unither Pharmaceutical Technologies 153

12 Appendix 154

12.1 Research Methodology 155

12.1.1 Coverage 155

12.1.2 Secondary Research 155

12.1.3 Primary Research 156

12.1.4 Company Share Analysis 156

12.1.5 Distribution Share Analysis 156

12.1.6 Benchmarking 157

12.2 GlobalData Consulting 157

12.3 Contact Us 158

12.4 Disclaimer 158

1.2 List of Figures

Figure 1: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, 2009-2023 11

Figure 2: Drug Delivery Devices Market, France, Revenue Mix ($m), 2016 13

Figure 3: Drug Delivery Devices Market, France, Category Contribution (%), 2016 14

Figure 4: Drug Delivery Devices Market, France, Category Comparison by Revenue ($m), 2009-2023 15

Figure 5: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 16

Figure 6: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 18

Figure 7: Drug Delivery Devices Market, France, Volume (Units), 2009-2023 20

Figure 8: Drug Delivery Devices Market, France, Volume (Units), Historic, 2009-2016 22

Figure 9: Drug Delivery Devices Market, France, Volume (Units), Forecast, 2016-2023 24

Figure 10: Drug Delivery Devices Market, France, Company Share (%) 2016 26

Figure 11: Central Venous Catheters Market, France, Revenue Mix ($m), 2016 28

Figure 12: Central Venous Catheters Market, France, Segment Contribution (%), 2016 29

Figure 13: Central Venous Catheters Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 30

Figure 14: Central Venous Catheters Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 32

Figure 15: Central Venous Catheters Market, France, Volume (Units), Historic, 2009-2016 34

Figure 16: Central Venous Catheters Market, France, Volume (Units), Forecast, 2016-2023 36

Figure 17: Central Venous Catheters Market, France, Company Share (%) 2016 39

Figure 18: Infusion Systems Market, France, Revenue Mix ($m), 2016 41

Figure 19: Infusion Systems Market, France, Segment Contribution (%), 2016 42

Figure 20: Infusion Systems Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 43

Figure 21: Infusion Systems Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 45

Figure 22: Ambulatory Infusion Pumps Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 47

Figure 23: Syringe Pumps Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 49

Figure 24: Ambulatory Infusion Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 51

Figure 25: Syringe Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 53

Figure 26: Infusion Systems Market, France, Volume (Units), Historic, 2009-2016 55

Figure 27: Infusion Systems Market, France, Volume (Units), Forecast, 2016-2023 57

Figure 28: Ambulatory Infusion Pumps Market, France, Volume (Units), Historic, 2009-2016 59

Figure 29: Syringe Pumps Market, France, Volume (Units), Historic, 2009-2016 61

Figure 30: Ambulatory Infusion Pumps Market, France, Volume (Units), Forecast, 2016-2023 63

Figure 31: Syringe Pumps Market, France, Volume (Units), Forecast, 2016-2023 65

Figure 32: Infusion Systems Market, France, Company Share (%) 2016 68

Figure 33: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 70

Figure 34: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 71

Figure 35: Metered Dose Inhaler Devices Market, France, Volume (Units), Historic, 2009-2016 72

Figure 36: Metered Dose Inhaler Devices Market, France, Volume (Units), Forecast, 2016-2023 73

Figure 37: Metered Dose Inhaler Devices Market, France, Company Share (%) 2016 75

Figure 38: Needle Free Injections Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 77

Figure 39: Needle Free Injections Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 78

Figure 40: Needle Free Injections Market, France, Volume (Units), Historic, 2009-2016 79

Figure 41: Needle Free Injections Market, France, Volume (Units), Forecast, 2016-2023 80

Figure 42: Needle Free Injections Market, France, Company Share (%) 2016 82

1.1 List of Tables

Table 1: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, 2009-2023 12

Table 2: Drug Delivery Devices Market, France, Category Contribution by Revenue ($m), 2016 14

Table 3: Drug Delivery Devices Market, France, Category Comparison by Revenue ($m), 2009-2023 15

Table 4: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 17

Table 5: Drug Delivery Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 19

Table 6: Drug Delivery Devices Market, France, Volume (Units), 2009-2023 21

Table 7: Drug Delivery Devices Market, France, Volume (Units), Historic, 2009-2016 23

Table 8: Drug Delivery Devices Market, France, Volume (Units), Forecast, 2016-2023 25

Table 9: Drug Delivery Devices Market, France, Company Share by Revenue ($m), USD Constant, 2016 27

Table 10: Central Venous Catheters Market, France, Segment Contribution (%), 2016 29

Table 11: Central Venous Catheters Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 31

Table 12: Central Venous Catheters Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 33

Table 13: Central Venous Catheters Market, France, Volume (Units), Historic, 2009-2016 35

Table 14: Central Venous Catheters Market, France, Volume (Units), Forecast, 2016-2023 37

Table 15: Central Venous Catheters Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016 38

Table 16: Central Venous Catheters Market, France, Company Share by Revenue ($m), USD Constant, 2016 40

Table 17: Infusion Systems Market, France, Segment Contribution (%), 2016 42

Table 18: Infusion Systems Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 44

Table 19: Infusion Systems Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 46

Table 20: Ambulatory Infusion Pumps Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 48

Table 21: Syringe Pumps Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 50

Table 22: Ambulatory Infusion Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 52

Table 23: Syringe Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 54

Table 24: Infusion Systems Market, France, Volume (Units), Historic, 2009-2016 56

Table 25: Infusion Systems Market, France, Volume (Units), Forecast, 2016-2023 58

Table 26: Ambulatory Infusion Pumps Market, France, Volume (Units), Historic, 2009-2016 60

Table 27: Syringe Pumps Market, France, Volume (Units), Historic, 2009-2016 62

Table 28: Ambulatory Infusion Pumps Market, France, Volume (Units), Forecast, 2016-2023 64

Table 29: Syringe Pumps Market, France, Volume (Units), Forecast, 2016-2023 66

Table 30: Infusion Systems Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016 67

Table 31: Infusion Systems Market, France, Company Share by Revenue ($m), USD Constant, 2016 69

Table 32: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 70

Table 33: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 71

Table 34: Metered Dose Inhaler Devices Market, France, Volume (Units), Historic, 2009-2016 72

Table 35: Metered Dose Inhaler Devices Market, France, Volume (Units), Forecast, 2016-2023 73

Table 36: Metered Dose Inhaler Devices Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016 74

Table 37: Metered Dose Inhaler Devices Market, France, Company Share by Revenue ($m), USD Constant, 2016 76

Table 38: Needle Free Injections Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 77

Table 39: Needle Free Injections Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 78

Table 40: Needle Free Injections Market, France, Volume (Units), Historic, 2009-2016 79

Table 41: Needle Free Injections Market, France, Volume (Units), Forecast, 2016-2023 80

Table 42: Needle Free Injections Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016 81

Table 43: Needle Free Injections Market, France, Company Share by Revenue ($m), USD Constant, 2016 83

Table 44: Drug Delivery Devices Market Pipeline Products 88

Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 93

Table 46: Alimera Sciences Enters into Licensing Agreement with pSivida 95

Table 47: Bluegrass Vascular Enters into Partnership with Merit Medical 96

Table 48: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 97

Table 49: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 98

Table 50: Propeller Health Enters into Agreement with Novartis Pharma 100

Table 51: Neuronex Enters Into Licensing Agreement With SK Biopharmaceuticals For DZNS Technology 101

Table 52: Pfizer Terminates its Licensing Agreement with pSivida 102

Table 53: Biocorp Production Enters into Licensing Agreement 103

Table 54: Bayer Enters into Licensing Agreement with DelSiTech 104

Table 55: BioCorRx Enters into Licensing Agreement with Therakine 105

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

B. Braun Melsungen AG

GlaxoSmithKline Plc

Baxter International Inc

AstraZeneca Plc

Becton Dickinson and Co

Boehringer Ingelheim GmbH

Fresenius Kabi AG

Pfizer Inc

Merck & Co Inc

Medtronic Plc

Smiths Medical

Terumo Corp

Hospira Inc

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

select a license
Single User License
USD 5995 INR 430381
Site License
USD 11990 INR 860762
Corporate User License
USD 17985 INR 1291143

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com